Actinogen Medical Stock Fundamentals
| ACW Stock | 0.03 0 8.33% |
Actinogen Medical fundamentals help investors to digest information that contributes to Actinogen Medical's financial success or failures. It also enables traders to predict the movement of Actinogen Stock. The fundamental analysis module provides a way to measure Actinogen Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Actinogen Medical stock.
At this time, Actinogen Medical's Net Interest Income is comparatively stable compared to the past year. Reconciled Depreciation is likely to gain to about 425.3 K in 2024, despite the fact that Operating Income is likely to grow to (12.2 M). Actinogen | Select Account or Indicator |
Actinogen Medical Company Current Valuation Analysis
Actinogen Medical's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Actinogen Medical Current Valuation | 64.85 M |
Most of Actinogen Medical's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Actinogen Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Actinogen Medical has a Current Valuation of 64.85 M. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The current valuation for all Australia stocks is notably lower than that of the firm.
Actinogen Medical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Actinogen Medical's current stock value. Our valuation model uses many indicators to compare Actinogen Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Actinogen Medical competition to find correlations between indicators driving Actinogen Medical's intrinsic value. More Info.Actinogen Medical is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Actinogen Medical's earnings, one of the primary drivers of an investment's value.Actinogen Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Actinogen Medical's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Actinogen Medical could also be used in its relative valuation, which is a method of valuing Actinogen Medical by comparing valuation metrics of similar companies.Actinogen Medical is currently under evaluation in current valuation category among its peers.
Actinogen Fundamentals
| Return On Equity | -0.79 | ||||
| Return On Asset | -0.45 | ||||
| Profit Margin | (1.31) % | ||||
| Operating Margin | (0.18) % | ||||
| Current Valuation | 64.85 M | ||||
| Shares Outstanding | 3.08 B | ||||
| Shares Owned By Insiders | 15.60 % | ||||
| Shares Owned By Institutions | 8.02 % | ||||
| Price To Book | 3.76 X | ||||
| Price To Sales | 8.07 X | ||||
| Revenue | 9.93 M | ||||
| Gross Profit | 4.89 M | ||||
| EBITDA | (12.92 M) | ||||
| Net Income | (13.04 M) | ||||
| Cash And Equivalents | 7.18 M | ||||
| Total Debt | 319.07 K | ||||
| Book Value Per Share | 0.01 X | ||||
| Cash Flow From Operations | (16.95 M) | ||||
| Earnings Per Share | (0.01) X | ||||
| Target Price | 0.15 | ||||
| Beta | 1.23 | ||||
| Market Capitalization | 80.15 M | ||||
| Total Asset | 21.31 M | ||||
| Retained Earnings | (81.74 M) | ||||
| Working Capital | 17.52 M | ||||
| Net Asset | 21.31 M |
About Actinogen Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Actinogen Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Actinogen Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Actinogen Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 582.2 K | 611.3 K | |
| Total Revenue | 9.9 M | 10.4 M | |
| Cost Of Revenue | 416.8 K | 334.9 K |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Actinogen Stock Analysis
When running Actinogen Medical's price analysis, check to measure Actinogen Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Actinogen Medical is operating at the current time. Most of Actinogen Medical's value examination focuses on studying past and present price action to predict the probability of Actinogen Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Actinogen Medical's price. Additionally, you may evaluate how the addition of Actinogen Medical to your portfolios can decrease your overall portfolio volatility.